capecitabine has been researched along with Cancer Syndromes, Hereditary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creemers, GM; de Jongh, FE; de Leng, WWJ; Elias, SG; Erdkamp, FLG; Goey, KKH; Koopman, M; Laclé, MM; Offerhaus, GJA; Punt, CJA; Strengman, E; Tanis, BC; Ten Tije, AJ; van der Velden, A; van Tinteren, H; Willems, SM | 1 |
Qiu, H; Zhou, Z | 1 |
1 trial(s) available for capecitabine and Cancer Syndromes, Hereditary
Article | Year |
---|---|
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Capecitabine; Colorectal Neoplasms; Disease-Free Survival; DNA Mismatch Repair; Female; Humans; Male; Middle Aged; Mutation; Neoplasm Metastasis; Neoplastic Syndromes, Hereditary; Observation; Proto-Oncogene Proteins B-raf; ras Proteins; Treatment Outcome | 2017 |
1 other study(ies) available for capecitabine and Cancer Syndromes, Hereditary
Article | Year |
---|---|
[Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5].
Topics: Biomarkers, Tumor; Capecitabine; DNA Mismatch Repair; Humans; Microsatellite Instability; Neoplastic Syndromes, Hereditary; Stomach Neoplasms | 2018 |